Concepedia

Linda Hylander-Gans

LH

Statistics

Publications

3

Citations

508

H-Index

3

Active since

2004

Affiliations

AstraZeneca (United States)(Current)

University of Michigan

Michigan Center for Translational Pathology

U-M Rogel Cancer Center

Linda Hylander-Gans is an author at AstraZeneca (United States) specializing in dna damage, tumor microenvironment, and cancer therapeutics.

Top concepts

Publications per year

2004–2011

3

Publications

3

Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2 Checkpoint and Inhibition of Homologous Recombinational DNA Repair

Meredith A. Morgan, Leslie A. Parsels, Lili Zhao et al. · Cancer Research · 2010 · 296 citations · Full text

, , +17

Cytotoxic activity of the maytansinoid immunoconjugate B-B4–DM1 against CD138+ multiple myeloma cells

Pierfrancesco Tassone, Victor S. Goldmacher, Paola Neri et al. · Blood · 2004 · 124 citations · Full text

Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition

Leslie A. Parsels, Yushen Qian, Daria M. Tanska et al. · Clinical Cancer Research · 2011 · 88 citations · Full text

1–3 of 3